Handelsbanken Fonder AB
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1398318
STOCKHOLM, V7
Position in REGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$32,628,601
-$63,979,214 QoQ
Shares Held
52,328
-58.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2
of 91 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. REGN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,628,601 | 52,328 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $96,607,815 | 125,036 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $77,731,940 | 100,706 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $35,450,561 | 63,049 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $26,513,550 | 50,502 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,494,231 | 46,504 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $34,301,538 | 48,154 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $87,925,713 | 83,640 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $91,545,764 | 87,101 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $101,183,686 | 105,127 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $83,472,681 | 95,040 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $106,183,236 | 129,026 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $95,966,765 | 133,558 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $125,131,302 | 152,289 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $130,285,942 | 180,579 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $142,334,319 | 206,620 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $114,868,381 | 194,320 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $138,105,570 | 197,740 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $116,035,484 | 183,740 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $93,453,711 | 154,423 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $11,407,062 | 20,423 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $11,997,410 | 25,357 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $11,942,479 | 24,720 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $17,917,438 | 32,008 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,278,161 | 45,343 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $4,882,900 | 10,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||